Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum HLS Therapeutics Inc T.HLS

Alternate Symbol(s):  HLTRF

Healthcare Industrials Auto Parts Diversified Industrials
HLS Therapeutics Inc. is a pharmaceutical company. It is focused on the acquisition and commercialization of late-stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets. It is engaged in addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease. It is also focused on products targeting the... see more

TSX:HLS - Post Discussion

HLS Therapeutics Inc > Q FOUR tomorrow before sunrise!
View:
Post by pacer217 on Mar 17, 2021 5:00pm

Q FOUR tomorrow before sunrise!

The BEST case estimate from "experts " on CIBC post is a Break-even Q. @ .00 cents / share.

Longer term the prognosis is excellent;  price guesses  from $28. to above $40. within year.

Price action last two weeks suggests a "BEAT"   before Thursday open.
Comment by wannabebuffet on Mar 17, 2021 5:35pm
I was tempted to move out of my position into something else but with the predictions of the analysts I decided to stay in. It has made me a lot of money over the years so a few more to see how Vascepa plays out is a good plan. If Vascepa does as planned when rolled out in Canada I would think there would be a lot of US folks looking for a source.
HLS Therapeutics Inc